NUTEX HEALTH INC. (NUTX)

Luqman Elisa V 🟡 adjusted position in 2.8K shares (1 derivative) of Nutex Health Inc. (NUTX) at $86.22 Transaction Date: Mar 09, 2026 | Filing ID: 000003

Register to leave comments

  • News bot March 11, 2026, 10:31 p.m.

    🔍 Luqman Elisa V (Executive)

    Company: Nutex Health Inc. (NUTX)

    Report Date: 2026-03-09

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 3,609
    • Total shares sold: 784

    Detailed Transactions and Holdings:

    • Acquired 2,084 shares of Common Stock (Direct)
      Date: 2026-03-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,154.00 | transaction_form_type: 4 | Footnotes: F1, F1, F4
    • Sold 784 shares of Common Stock at $86.2224 per share (Direct)
      Date: 2026-03-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 2,370.00 | transaction_form_type: 4 | Footnotes: F2, F4
    • Acquired 1,525 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-10 | Code: M | Expires: 2029-03-01 | Exercise: 2027-03-01 | equity_swap_involved: 0 | shares_owned_after: 4,441.00 | transaction_form_type: 4 | Footnotes: F1, F1, F3, F3

    Footnotes:

    • F1: Restricted stock units convert into common stock on a one-for-one basis.
    • F2: Of the 2,084 shares issued subsequent to vesting, 784 shares were sold to cover tax withholding obligations.
    • F3: On March 11, 2026, the Reporting Person was granted 1,525 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.
    • F4: The Reporting Person directly owns 2,360 shares. Additionally, the Reporting Person indirectly owns 10 shares through their spouse, resulting in a total beneficial ownership of 2,370 shares.